US OptionsDetailed Quotes
VNDA250117C3000
- 0.00
- 0.000.00%
15min DelayTrading Jan 2 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest3.00Strike Price0.00Turnover438.31%IV-37.76%PremiumJan 17, 2025Expiry Date1.82Intrinsic Value100Multiplier15DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8361Delta0.0576Gamma1.99Leverage Ratio-0.0359Theta0.0007Rho1.66Eff Leverage0.0024Vega
Vanda Pharmaceuticals Newsroom
Vanda Pharma Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Vanda Pharma, Maintains $18 Price Target
Vanda Pharmaceuticals: Promising Pipeline Developments and Market Potential Drive Buy Rating
H.C. Wainwright Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Maintains Target Price $18
Cantor Fitzgerald Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Maintains Target Price $13
Vanda Pharma Analyst Ratings
H.C. Wainwright Initiates Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Announces Target Price $18
Vanda Pharma Analyst Ratings
Cantor Fitzgerald Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Raises Target Price to $13
Vanda Pharma Analyst Ratings
No More